Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
March 11th, 2024 |
HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional) |
National Institutes of Health |
February 1st, 2023 |
Fiscal Year (FY) 2023 AmeriCorps Seniors Workforce Development |
AmeriCorps |
March 15th, 2023 |
Targeting Inflammasomes in Substance Abuse and HIV (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
March 16th, 2023 |
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 3rd, 2023 |
Madagascar Urban Sanitation Project Addendum |
Madagascar USAID Antananarivo |
March 29th, 2023 |
Pediatric Critical Care and Trauma Scientist Development Program (K12 Clinical Trial Optional) |
National Institutes of Health |
March 14th, 2025 |
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
January 10th, 2023 |
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
March 24th, 2023 |
Strengthening Regional, National, and Subnational Institutional Capacities to Sustainably Combat HIV/AIDS and Tuberculosis under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
April 4th, 2023 |
Technical Assistance Services and Programmatic Support to Address National TB Program Needs and Priorities Towards Their Efforts to End TB |
Centers for Disease Control CGH |
March 13th, 2023 |
Strengthening Scale Up of HIV Prevention, Care and Treatment Programs in South Sudan under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 24th, 2023 |
Multi-Regional Mechanism for Accelerating and Sustaining Epidemic Control in the Republic of Uganda through the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 27th, 2023 |
Strengthening Local Capacity to Deliver Comprehensive HIV/AIDS Prevention, Care and Treatment Activities in the Republic of Cote d'Ivoire under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 27th, 2023 |
Strengthening Local Capacity to Deliver HIV/AIDS Prevention, Care and Treatment Activities for Key Populations in the Republic of Cote d'Ivoire under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 24th, 2023 |
Strengthening the Quality, Accessibility, and Sustainability of the National Health Laboratory System (NHLS) in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 24th, 2023 |
Sustain and Accelerate a Comprehensive HIV Response in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 26th, 2023 |
Implementing Innovative Activities to Reach Epidemic Control in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 13th, 2023 |
Strengthening an Integrated Comprehensive Approach for HIV Services for Adolescents and Young People through Determined, Resilient, AIDS-Free Mentored and Safe (DREAMS) Program in Zimbabwe under the President's |
Centers for Disease Control CGH |
March 13th, 2023 |
Sustainable, Innovative, and Agile Community and Facility HIV Prevention, Care and Treatment Services for Epidemic Control among all Populations in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
April 4th, 2023 |
Supporting Continuous Quality Improvement, Partnerships, and Innovation for Sustained and Responsive Laboratory Systems, Tiered Diagnostic Networks, and Laboratory Data Management under the President's Emergency Plan |
Centers for Disease Control CGH |
|
March 28th, 2023 |
Technical Assistance to National Entities and Regional Health Bureaus (RHBs) in the Implementation of HIV Programs across Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 27th, 2023 |
Enhancing Comprehensive Community-Based and Sustainable HIV/AIDS Key Population (KP) Prevention Services and Treatment Support for KP Living with HIV in the Republic of Zambia under PEPFAR |
Centers for Disease Control CGH |
March 26th, 2023 |
Transitioning and Integrating Laboratory Services for High Quality HIV Diagnosis, Care, Treatment, and Monitoring to the Ministry of Health (MOH) to Sustain Achievement of the 95-95-95 Goals in Zambia under PEPFAR |
Centers for Disease Control CGH |
March 27th, 2023 |
Enhancing the Quality and Reach of Comprehensive and Sustainable HIV/AIDS Prevention Services in the Republic of Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 7th, 2023 |
Provision of Voluntary Medical Male Circumcision (VMMC) for HIV Prevention in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 13th, 2023 |
Scaling-up Sustainable Voluntary Medical Male Circumcision (VMMC) through Improvements in the Availability, Integration, and Quality of HIV Prevention Services in Zimbabwe under the President's Emergency Plan for AIDS |
Centers for Disease Control CGH |
July 28th, 2025 |
Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
January 10th, 2023 |
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 25th, 2025 |
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2025 |
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
July 5th, 2025 |
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01) |
National Institutes of Health |
May 25th, 2025 |
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed) |
National Institutes of Health |
September 7th, 2025 |
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
September 5th, 2025 |
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
National Institutes of Health |
November 16th, 2022 |
USAID/Bangladesh Request for Information on USAID's Accelerating Reductions in Adolescent Childbearing |
Bangladesh USAID Dhaka |
March 13th, 2023 |
Strengthening Laboratory Systems that Support Diagnosis, Treatment, Prevention, and Management of HIV/AIDS and Related Public Health Diseases in the Republic of South Sudan under the President's Emergency Plan for AIDS |
Centers for Disease Control CGH |
January 6th, 2023 |
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) |
National Institutes of Health |
January 6th, 2023 |
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) |
National Institutes of Health |
January 23rd, 2023 |
Achieving and Sustaining HIV/TB Epidemic Control in the Limpopo Province |
South Africa USAID Pretoria |
January 17th, 2023 |
Achieving and Sustaining HIV/TB Epidemic Control in the KwaZulu-Natal Province Achieving and Sustaining HIV/TB Epidemic Control in the KwaZulu-Natal Province |
South Africa USAID Pretoria |